Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing deviation in 12-hour standard serum clozapine monitoring
2015-002520-82Phase 4Completed
- Sponsor
- Prof., dr. med. Anders Fink-Jensen
- Start
- Jul 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of clozapine in schizophrenia, sponsored by Prof., dr. med. Anders Fink-Jensen. Primary endpoints: Relative change in serum clozapine over 10–14 hours post-dose and Relative change in serum N-desmethylclozapine over 10–14 hours post-dose. Started Jul 2015; status: completed.
02
Drugs
clozapine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2015-002520-82.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-002520-82.